Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database

Abstract

The validity of ovarian cancer data in the DGCD is sufficient for quality monitoring in gynecological oncology.

Demographic Clinical and Prognostic Factors of Primary Ovarian Adenocarcinomas of Serous and Clear Cell Histology—A Comparative Study

“…Reporting to the DGCD is compulsory for all gynecological, pathological, and oncological departments in Denmark who are participating in the diagnosis and treatment of these cancers. 6 Lifelong follow-up of cases is possible through linkage via personal identification number to the Danish Hospital Discharge register, which contains data on death and discharge diagnoses among others.…”

Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology — A prospective comparative study

“…The study is based on prospectively collected data from DGCD, which holds information on 97% of Danish patients diagnosed with ovarian cancer since January 1st, 2005 [5]. The pathologists have special focus on discriminating between peritoneal, ovarian and fallopian tube involvement and origin.…”

Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

“…For each patient, data are collected on surgical, pathological, and oncological variables. A validation study found 94% of cases to be covered in the database, and surgical and pathological data to be sufficient for research [14]. However, oncological data are incomplete since some oncological departments have not had the resources to fill the forms in the database [15].…”